175 related articles for article (PubMed ID: 28321110)
1. Primary Pulmonary Diffuse Large B Cell Non-Hodgkin's Lymphoma: A Case Report and Literature Review.
Zhu Z; Liu W; Mamlouk O; O'Donnell JE; Sen D; Avezbakiyev B
Am J Case Rep; 2017 Mar; 18():286-290. PubMed ID: 28321110
[TBL] [Abstract][Full Text] [Related]
2. Diffuse Large B-Cell Lymphoma Arising from the Lesion of Chronic Lobar Atelectasis.
Fujita N; Ando M; Goto A; Sakata M; Ogata M; Usagawa Y; Yoshikawa H; Yamasue M; Komiya K; Umeki K; Nureki SI; Kadota JI
Tohoku J Exp Med; 2020 Feb; 250(2):129-135. PubMed ID: 32115495
[TBL] [Abstract][Full Text] [Related]
3. Non-Hodgkin's lymphoma accompanied by pulmonary involvement with diffuse ground-glass opacity on chest CT: a report of 2 cases.
Tokuyasu H; Harada T; Watanabe E; Touge H; Kawasaki Y; Endo A; Maeda R; Isowa N; Ohnuma H; Miura H; Shimizu E
Intern Med; 2009; 48(2):105-9. PubMed ID: 19145055
[TBL] [Abstract][Full Text] [Related]
4. Complete Remission and Long-term Survival of a Patient with a Diffuse Large B-cell Lymphoma Under
Gutsch J; Werthmann PG; Rosenwald A; Kienle GS
Anticancer Res; 2018 Sep; 38(9):5363-5369. PubMed ID: 30194190
[TBL] [Abstract][Full Text] [Related]
5. Matched-pair analysis comparing the outcomes of primary breast and nodal diffuse large B-cell lymphoma in patients treated with rituximab plus chemotherapy.
Yhim HY; Kim JS; Kang HJ; Kim SJ; Kim WS; Choi CW; Eom HS; Kim JA; Lee JH; Won JH; Shim H; Huh J; Lee DH; Suh C; Kwak JY
Int J Cancer; 2012 Jul; 131(1):235-43. PubMed ID: 21823120
[TBL] [Abstract][Full Text] [Related]
6. Diffuse large B-cell lymphoma solely involving bilateral adrenal glands and stomach: report of an extremely rare case with review of the literature.
Wakabayashi M; Sekiguchi Y; Shimada A; Ichikawa K; Sugimoto K; Tomita S; Izumi H; Nakamura N; Sawada T; Ohta Y; Komatsu N; Noguchi M
Int J Clin Exp Pathol; 2014; 7(11):8190-7. PubMed ID: 25550871
[TBL] [Abstract][Full Text] [Related]
7. Everolimus combined with R-CHOP-21 for new, untreated, diffuse large B-cell lymphoma (NCCTG 1085 [Alliance]): safety and efficacy results of a phase 1 and feasibility trial.
Johnston PB; LaPlant B; McPhail E; Habermann TM; Inwards DJ; Micallef IN; Colgan JP; Nowakowski GS; Ansell SM; Witzig TE
Lancet Haematol; 2016 Jul; 3(7):e309-16. PubMed ID: 27374464
[TBL] [Abstract][Full Text] [Related]
8. Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group.
Staiger AM; Ziepert M; Horn H; Scott DW; Barth TFE; Bernd HW; Feller AC; Klapper W; Szczepanowski M; Hummel M; Stein H; Lenze D; Hansmann ML; Hartmann S; Möller P; Cogliatti S; Lenz G; Trümper L; Löffler M; Schmitz N; Pfreundschuh M; Rosenwald A; Ott G;
J Clin Oncol; 2017 Aug; 35(22):2515-2526. PubMed ID: 28525305
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic T/histiocyte-rich large B-cell lymphoma: A case report and review of literature.
Zheng SM; Zhou DJ; Chen YH; Jiang R; Wang YX; Zhang Y; Xue HL; Wang HQ; Mou D; Zeng WZ
World J Gastroenterol; 2017 Jun; 23(24):4467-4472. PubMed ID: 28706431
[TBL] [Abstract][Full Text] [Related]
10. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ
Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700
[TBL] [Abstract][Full Text] [Related]
11. A case of diffuse large B-cell lymphoma of the lung demonstrating diffuse ground-glass shadows.
Ogata-Suetsugu S; Maeyama T; Takeshita M; Hamada N; Takayama K; Inoue H; Nakanishi Y
Ann Thorac Cardiovasc Surg; 2011; 17(6):591-4. PubMed ID: 21881351
[TBL] [Abstract][Full Text] [Related]
12. Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort.
Evens AM; Kanakry JA; Sehn LH; Kritharis A; Feldman T; Kroll A; Gascoyne RD; Abramson JS; Petrich AM; Hernandez-Ilizaliturri FJ; Al-Mansour Z; Adeimy C; Hemminger J; Bartlett NL; Mato A; Caimi PF; Advani RH; Klein AK; Nabhan C; Smith SM; Fabregas JC; Lossos IS; Press OW; Fenske TS; Friedberg JW; Vose JM; Blum KA
Am J Hematol; 2015 Sep; 90(9):778-83. PubMed ID: 26044261
[TBL] [Abstract][Full Text] [Related]
13. The unexpected evolution of a case of diffuse large B-cell non-Hodgkin lymphoma.
Găman A; Bold A; Găman G
Rom J Morphol Embryol; 2011; 52(2):719-22. PubMed ID: 21655667
[TBL] [Abstract][Full Text] [Related]
14. A rare case of anaplastic variant of diffuse large B-cell lymphoma presenting as a lung primary.
Kos Z; Burns BF; Gomes MM; Sekhon HS
Int J Surg Pathol; 2014 Apr; 22(2):167-71. PubMed ID: 23775019
[TBL] [Abstract][Full Text] [Related]
15. [Clinical characteristics and treatment strategies for early-stage primary gastric diffuse large B-cell lymphoma].
Qin Y; Liu P; Yang JL; Jin J; He XH; Wang WH; Fang H; Zhou SY; Zhou LQ; Song YW; Shi YK
Zhonghua Yi Xue Za Zhi; 2018 Jun; 98(24):1945-1950. PubMed ID: 29996288
[No Abstract] [Full Text] [Related]
16. Interim fluorine-18 fluorodeoxyglucose PET-computed tomography and cell of origin by immunohistochemistry predicts progression-free and overall survival in diffuse large B-cell lymphoma patients in the rituximab era.
de Oliveira Costa R; Hallack Neto A; Siqueira S; Lage LA; de Paula HM; Coutinho AM; Pereira J
Nucl Med Commun; 2016 Oct; 37(10):1095-101. PubMed ID: 27281359
[TBL] [Abstract][Full Text] [Related]
17. Partial remission of a newly diagnosed diffuse large B-cell Non-Hodgkin's lymphoma in a hemodialysis patient after administration of immuno-chemotherapy with rituximab-CHOP.
Feldmann G; Nattermann J; Gerhardt T; Nähle CP; Spengler U; Woitas R
Int J Lab Hematol; 2007 Dec; 29(6):469-73. PubMed ID: 17988304
[TBL] [Abstract][Full Text] [Related]
18. Primary nasal diffuse large B-cell lymphoma with synchronous pulmonary involvement: A case report.
Hao S; Sun Y; Hu C; Zhi Y; Xiao H; Li Y
Medicine (Baltimore); 2019 Apr; 98(17):e15439. PubMed ID: 31027146
[TBL] [Abstract][Full Text] [Related]
19. Prognostic implications of extranodal involvement in patients with diffuse large B-cell lymphoma treated with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone.
Hui D; Proctor B; Donaldson J; Shenkier T; Hoskins P; Klasa R; Savage K; Chhanabhai M; Gascoyne RD; Connors JM; Sehn LH
Leuk Lymphoma; 2010 Sep; 51(9):1658-67. PubMed ID: 20795790
[TBL] [Abstract][Full Text] [Related]
20. Treatment of aggressive non-Hodgkin's lymphoma: a north American perspective.
Sehn LH; Connors JM
Oncology (Williston Park); 2005 Apr; 19(4 Suppl 1):26-34. PubMed ID: 15934515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
